The global neurovascular devices market estimated to be valued US $ 2.48 Bn in 2020 and poised to grow at significant CAGR nearly 8.3% over 2021-2027. Some of the factors propelling the market growth due to rising geriatric population they have greater risk to prone various diseases and disorders such as cerebrovascular, neurological and others. Additionally, accessibility to advance medical facilities for diagnosis and treatment will positively impact the market growth. Furthermore, upgrading in technology and new advance innovations in the medical facility will fuel the market growth. However, high cost of the treatment, lack of skilled professional and lack of awareness among the individuals will hinder the market growth. Aneurysms are caused by an increase in the prevalence of hypertension, alcohol intake, and smoking. An estimated 6 million Americans are impacted by brain aneurysms each year, according to the Brain Aneurysm Foundation. Every year, the disease claims the lives of half a million people around the world. In the creation of neurothrombectomy devices for the treatment of AIS and accompanying symptoms, a variety of additional technologies are applied. As a result, market expansion is likely to be fueled by the launch of technologically improved items and a quick product approval procedure. The report on Neurovascular Devices Market studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).